As shown in Fig. 3, the expression of YTHDF1, YTHDF2, YTHDC1, RBM15 and METTL3 was found to be significantly associated with HCC staging, whereas other genes did not have a significant relationship with the clinical stages of HCC. This evidence concerns the gene RBM15 and hepatocellular carcinoma.